Lymphocyte activation during acute simian/human immunodeficiency virus SHIV89.6PD infection in macaques

被引:22
作者
Wallace, M
Waterman, PM
Mitchen, JL
Djavani, M
Brown, C
Trivedi, P
Horejsh, D
Dykhuizen, M
Kitabwalla, M
Pauza, CD
机构
[1] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA
[2] Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53705 USA
[3] NIH, Immunodeficiency Viruses Sect, Infect Dis Lab, Rockville, MD 20852 USA
关键词
D O I
10.1128/JVI.73.12.10236-10244.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Host-virus interactions control disease progression in human immunodeficiency virus-infected human beings and in nonhuman primates infected with simian or simian/human immunodeficiency viruses (SHIV). These interactions evolve rapidly during acute infection and are key to the mechanisms of viral persistence and AIDS. SHIV89.6PD infection in rhesus macaques can deplete CD4(+) T cells from the peripheral blood, spleen, and lymph nodes within 2 weeks after exposure and is a model for virulent, acute infection. Lymphocytes isolated from blood and tissues during the interval of acute SHIV89.6PD infection have lost the capacity to proliferate in response to phytohemagglutinin (PHA). T-cell unresponsiveness to mitogen occurred within 1 week after mucosal inoculation yet prior to massive CD4(+) T-cell depletion and extensive virus dissemination. The lack of mitogen response was due to apoptosis in vitro, and increased activation marker expression on circulating T cells in vivo coincided with the appearance of PHA-induced apoptosis in vitro. Inappropriately high immune stimulation associated with rapid loss of mature CD4(+) T cells suggested that activation-induced cell death is a mechanism for helper T-cell depletion in the brief period before widespread virus dissemination. Elevated levels of lymphocyte activation likely enhance SHIV89.6PD replication, thus increasing the loss of CD4(+) T cells and diminishing the levels of virus-specific immunity that remain after acute infection. The level of surviving immunity may dictate the capacity to control virus replication and disease progression. We describe this level of immune competence as the host set point to show its pivotal role in AIDS pathogenesis.
引用
收藏
页码:10236 / 10244
页数:9
相关论文
共 34 条
[1]   CROSS-LINKING CD4 BY HUMAN IMMUNODEFICIENCY VIRUS-GP120 PRIMES T-CELLS FOR ACTIVATION-INDUCED APOPTOSIS [J].
BANDA, NK ;
BERNIER, J ;
KURAHARA, DK ;
KURRLE, R ;
HAIGWOOD, N ;
SEKALY, RP ;
FINKEL, TH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1099-1106
[2]   HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION [J].
CLARK, SJ ;
SAAG, MS ;
DECKER, WD ;
CAMPBELLHILL, S ;
ROBERSON, JL ;
VELDKAMP, PJ ;
KAPPES, JC ;
HAHN, BH ;
SHAW, GM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :954-960
[3]   Host factors in the pathogenesis of HIV disease [J].
Cohen, OJ ;
Kinter, A ;
Fauci, AS .
IMMUNOLOGICAL REVIEWS, 1997, 159 :31-48
[4]   HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J].
Connors, M ;
Kovacs, JA ;
Krevat, S ;
GeaBanacloche, JC ;
Sneller, MC ;
Flanigan, M ;
Metcalf, JA ;
Walker, RE ;
Falloon, J ;
Baseler, M ;
Stevens, R ;
Feuerstein, I ;
Masur, H ;
Lane, HC .
NATURE MEDICINE, 1997, 3 (05) :533-540
[5]   CHARACTERIZATION OF LYMPHOCYTE-T RESPONSES DURING PRIMARY INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COOPER, DA ;
TINDALL, B ;
WILSON, EJ ;
IMRIE, AA ;
PENNY, R .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :889-896
[6]   TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
DAAR, ES ;
MOUDGIL, T ;
MEYER, RD ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) :961-964
[7]   PROGRAMMED CELL-DEATH AND AIDS - SIGNIFICANCE OF T-CELL APOPTOSIS IN PATHOGENIC AND NONPATHOGENIC PRIMATE LENTIVIRAL INFECTIONS [J].
ESTAQUIER, J ;
IDZIOREK, T ;
DEBELS, F ;
BARRESINOUSSI, F ;
HURTREL, B ;
AUBERTIN, AM ;
VENET, A ;
MEHTALI, M ;
MUCHMORE, E ;
MICHEL, P ;
MOUTON, Y ;
GIRARD, M ;
AMEISEN, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9431-9435
[8]   APOPTOSIS OCCURS PREDOMINANTLY IN BYSTANDER CELLS AND NOT IN PRODUCTIVELY INFECTED-CELLS OF HIV-INFECTED AND SIV-INFECTED LYMPH-NODES [J].
FINKEL, TH ;
TUDORWILLIAMS, G ;
BANDA, NK ;
COTTON, MF ;
CURIEL, T ;
MONKS, C ;
BABA, TW ;
RUPRECHT, RM ;
KUPFER, A .
NATURE MEDICINE, 1995, 1 (02) :129-134
[9]   PROGRAMMED CELL-DEATH IN AIDS-RELATED HIV AND SIV INFECTIONS [J].
GOUGEON, ML ;
GARCIA, S ;
HEENEY, J ;
TSCHOPP, R ;
LECOEUR, H ;
GUETARD, D ;
RAME, V ;
DAUGUET, C ;
MONTAGNIER, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (06) :553-563
[10]   CD3-MEDIATED APOPTOSIS OF HUMAN MEDULLARY THYMOCYTES AND ACTIVATED PERIPHERAL T-CELLS - RESPECTIVE ROLES OF INTERLEUKIN-1, INTERLEUKIN-2, INTERFERON-GAMMA AND ACCESSORY CELLS [J].
GROUX, H ;
MONTE, D ;
PLOUVIER, B ;
CAPRON, A ;
AMEISEN, JC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1623-1629